The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B

Clinical and Investigative Medicine

Volumn 31, Issue 3, 2008, Pages

  Wei, Xiu Qing ^a   Guo, Yun Wei ^a   Liu, Jia Jun ^a   Wen, Zhuo Fu ^a   Yang, Shao Ji ^a   Yao, Ji Lu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TLR4 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; STAINING; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REFERENCE VALUE; TUMOR CELL LINE; UPREGULATION; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENDOTOXINS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 48649109740     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol, 1999,162:6503-9.
2. Ichiki Y, He XS, Shimoda S, et al. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun Rev 2005;4:82-95.
3. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45.
4. Andreakos E, Foxwell B, Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol Rev 2004;202:250-65.
5. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responsies. Nat Imunnol 2004;5:987-95.
6. Migita K, Abiru S, Nakamura M, et al. Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro. FEBS Lett 2004;569:235-9.
7. Kobayashi N, Takesue M, Kobayashi N, et al. Evaluation of toll-like receptor 4 gene expression of immortalized human liver cell lines. Transplant Proc 2003;35:431-2.
8. Liu S, Gallo DJ, Green AM, et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002;70:3433-42.
9. Vodovotz Y, Liu S, McCloskey C, et al. The hepatocyte as a microbial product-responsive cell. J Endotoxin Res 2001;7:365-73.
10. Panesar N, Tolman K, Mazuski JE. Endotoxin stimulates hepatocyte interleukin-6 production. J Surg Res 1999;85:251-28.
11. Saad B, Frei K, Scholl FA, et al. Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes. Eur J Biochem 1995;229:349-55.
12. Riordan SM, Skinner NA, Kurtovic J, et al. Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury. Inflamm Res 2006;55:279-85.
13. Mozer-Lisewska I, Sluzewski W, Kackzmarek M, et al. Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand J Immunol 2005;62:407-12.
14. Ohashi K, Burkart V, Flohé S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164:558-61.
15. de Graaf R, Kloppenburg G, Kitslaar PJ, et al. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 2006;8:1859-65.
16. Sozinov AS. Systemic endotoxemia during chronic viral hepatitis. Bull Exp Biol Med 2002;133:153-5.
17. Lohse AW, Dienes HP, Herkel J, et al. Expression of the 60 kDa heat shock protein in normal and inflamed liver. J Hepatol 1993;19:159-66.
18. Wei XQ, Wen ZF, Zheng FP, et al. Changes of Tolllike receptor (TLR) 2 and TLR4 on the peripheral blood mononuclear cells in patients with chronic hepatitis B and chronic severe hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2007;15:354-7.
19. Society of Infectious Diseases, Parasitology and Hepatology, Chinese Medical Association. The project of prevention and treatment for viral hepatitis. Zhonghua Gan Zang Bing Za Zhi 2000;8: 342-29.
20. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991;13:372-4.
21. Apolinario A, Majano PL, Alvarez-Pérez E, et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 2002;97:2861-70.
22. García-Monzón C, Martín-Pérez E, Iacono OL, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000;33:716-24.
23. Gutiérrez-Ruiz MC, Quiroz SC, Souza V, et al. Cytokines, growth factors, and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde, and LPS. Toxicology 1999;134:197-207.
24. Machida K, Cheng KT, Sung VM, et al. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006;80:866-74.
25. Wright MS, Clausen HK and Abrahamsen TG. Liver cells respond to Aspergillus fumigatus with an increase in C3 secretion and C3 gene expression as well as an expression increase in TLR2 and TLR4. Immunol Lett 2004;95:25-30.
26. Visvanathan K, Skinner NA, Thompson AJ, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007;45:102-10.
27. Powers KA, Szászi K, Khadaroo RG, et al. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 2006;203:1951-61.
28. Hassan F, Islam S, Tumurkhuu G, et al. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide. BMC Cancer 2006;6:281.
29. Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver 1997;17:83-7.
30. Ding W, Yin X. Dissection of the multiple mechanisms of TNF- induced apoptosis in liver injury. J Cell Mol Med 2004;8:445-54.
31. Wang JY, Wang XL, Liu P. Detection of serum TNFalpha, IFN-beta,IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol 1999;5:38-40.
32. Isogawa M, Robek MD, Furuichi Y, et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005;79:7269-72.
33. Prince JM, Levy RM, Yang R, et al. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 2006;202:407-17.
34. Wang H, Li ZY, Wu HS, et al. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway. Chin Med J (Engl) 2007;120:509-14.
35. Uesugi T, Froh M, Arteel GE, et al. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001;34:101-8.
36. Yohe HC, O'Hara KA, Hunt JA, et al. Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity. Am J Physiol Gastrointest Liver Physiol 2006;290:G1269-79.
37. Takayashiki T, Yoshidome H, Kimura F, et al. Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice. J Hepatol 2004;41:621-8.
38. Shimamoto A, Chong AJ, Yada M, et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006;114:I270-4.
39. Mitsuzawa H, Nishitani C, Hyakushima N, et al. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice. J Immunol 2006;177:8133-9.
40. Fort MM, Mozaffarian A, Stöver AG, et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 2005;174:6416-23.